A Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients with Non-Alcoholic Steatohepatitis (NASH)

Grants and Contracts Details

StatusFinished
Effective start/end date1/25/134/30/15

Funding

  • Premier Research International LLC: $7,500.00